⌘K

Login Start Free

Home/Insiders/Marks Gilbert Lynn

MG

SEC Insider//CIK 0001916940

Marks Gilbert Lynn

CIK 00019169401 companyMENLO PARK, CA

Transactions

10

Companies

1

Filings

10

CIK

0001916940

Recent Transactions

10 trades

Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (Right to Buy)
2026-02-20+20,400→ 20,400 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2026-01-12+11,560→ 75,309 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-10-10+10,367→ 63,749 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-07-10+11,875→ 53,382 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (Right to Buy)
2025-05-22+19,111→ 19,111 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-04-10+9,705→ 41,507 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-12-19+8,972→ 31,802 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (Right to Buy)
2024-06-19+64,503→ 64,503 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2023-06-07+23,742→ 23,742 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2022-05-12+10,362→ 10,362 total

Companies

1

AN2 Therapeutics, Inc.
Director
$ANTX

Recent Filings

10

Address

C/O AN2 THERAPEUTICS, INC. 1300 EL CAMINO REAL, SUITE 100

MENLO PARK, CA, 94025

View on SEC.gov